awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42018342-12002CBE-F330-4EBA-B96C-281B0857A4E2
Q42018342-12002CBE-F330-4EBA-B96C-281B0857A4E2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42018342-12002CBE-F330-4EBA-B96C-281B0857A4E2
Enzyme enhancers for the treatment of Fabry and Pompe disease.
P2860
Q42018342-12002CBE-F330-4EBA-B96C-281B0857A4E2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42018342-12002CBE-F330-4EBA-B96C-281B0857A4E2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
48d3e1c364faf7bcec0ae8bac024e9d4fa021e04
P2860
Treatment of Human Fibroblasts Carrying NPC1 Missense Mutations with MG132 Leads to an Improvement of Intracellular Cholesterol Trafficking.